Aug 28, 2018: Cascade Metrix was invited to participate in the Startup Company Showcase at the Diabetes Technology Meeting 2018!

April 2, 2016: Cascade Metrix in partnership with Purdue University’s Pharmacology Testing Facility (West Lafayette, IN) conducted a 3-day pilot study on two pigs. 

Feb 10, 2016: Cascade Metrix is pleased to release preliminary results (including videos) from ongoing studies in pig and rat models. 

May 10, 2015: Cascade Metrix presented a poster in the International Hospital Diabetes Meeting held in San Francisco, CA from May 8-9, 2015. The poster demonstrated the performance of the core platform technology in a preclinical setting in partnership with Purdue University School of Veterinary Medicine (West Lafayette, IN). The CMI device sampled blood from a swine model from a central (jugular) venous catheter and tracked the blood glucose concentration in a fully automated fashion over the study period. 

May 04, 2015: Cascade Metrix changes incorporation to an Limited Liability Company (LLC).

March 18 2015: Cascade Metrix has entered into a pre-clinical trial partnership with the Purdue Veterinary Medicine and the Translational Pharmacology in West Lafayette, IN.

Jan 2015: Cascade Metrix has completed the design and development of a 'pre-clinical' device that performs fully automated blood sampling and glucose measurement in lab animals. The system is based on the integration of a lab-quality reusable glucose sensor and a proprietary automated blood sample management system. The sensor has been sourced from CM's sensor partner, BST Biosensor Technology, GmbH - a leading European manufacturer and distributor of electrochemical sensor systems for glucose and lactate.

Jan, 2013: The USPTO issued Cascade Metrix its key patent on the automated blood sampling and analysis technology platform. The patent [# 8,348,844] titled "Automated blood sampler and analyzer" was issued on 8 Jan. 2013.

Mar 2012: Cascade Metrix enters into a collaborative partnership with a leading European manufacturer and distributor of electrochemical sensor systems for glucose and lactate. The company's name is  BST Biosensor Technology, GmbH [Berlin, Germany]

Aug 2010: Cascade Metrix's abstract is accepted for a poster presentation in the International Hospital Diabetes Conference [San Diego, CA; Oct 8-9, 2010].

Jan 2010: David T. Giddings, a veteran medical device executive joins CMI as the Chief Business Officer.

Oct 2009: Cascade Metrix is selected as a finalist in the Purdue University LifeSciences Business Plan championship from among 27 start-ups from across the nation. The company is featured in Inside Indiana Business and Journal and Courier

May 2009: World renowned analytical chemist, Peter T Kissinger joins the scientific advisory board of Cascade Metrix.

Oct 2008: Cascade Metrix signs an agreement with Philips (Philips Medical Systems Boeblingen GmbH) for interfacing the automated glucose monitoring system data with Philips patient's monitors through the Vuelink Interface

Aug 2008: Cascade Metrix submits an abstract at the 2008 Diabetes Technology Meeting based on the integration of its blood sampling system with standard blood glucose meters

Mar 2008: Cascade Metrix article is accepted and published in the Journal of Diabetes Science and Technology ["Automated Blood Sampling and Glucose Sensing in Critical Care Settings"; Kislaya Kunjan, Frank Lloyd; Journal of Diabetes Sci & Tech, 2008]

Sep 2007: The Chief Editor of the Journal of Diabetes Sci. and Technology, David Klonoff, MD., invites CMI to write an original article in the area of automated blood sampling and measurement in support of ICU tight glycemic control

Nov 2006: Cascade Metrix presents a poster in the Diabetes Technology Society meeting in Atlanta, GA ["Continuous Glucose Monitoring in Whole Blood using Mid IR Technology"] 

July 2006: Cascade Metrix, Inc. is registered as a C-corporation in the state of Indiana